These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2860743)

  • 21. Modification of dengue virus strains by passage in primary dog kidney cells: preparation of candidate vaccines and immunization of monkeys.
    Eckels KH; Dubois DR; Putnak R; Vaughn DW; Innis BL; Henchal EA; Hoke CH
    Am J Trop Med Hyg; 2003 Dec; 69(6 Suppl):12-6. PubMed ID: 14740950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of attenuation of a candidate dengue 1 vaccine (45AZ5) in human volunteers.
    McKee KT; Bancroft WH; Eckels KH; Redfield RR; Summers PL; Russell PK
    Am J Trop Med Hyg; 1987 Mar; 36(2):435-42. PubMed ID: 3826504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody.
    Lai CJ; Goncalvez AP; Men R; Wernly C; Donau O; Engle RE; Purcell RH
    J Virol; 2007 Dec; 81(23):12766-74. PubMed ID: 17881450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of Toxorhynchites splendens for identification and quantitation of serotypes contained in the tetravalent live attenuated dengue vaccine.
    Jirakanjanakit N; Khin MM; Yoksan S; Bhamarapravati N
    Vaccine; 1999 Feb; 17(6):597-601. PubMed ID: 10075167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chimeric dengue type 2/type 1 viruses induce immune responses in cynomolgus monkeys.
    Butrapet S; Rabablert J; Angsubhakorn S; Wiriyarat W; Huang C; Kinney R; Punyim S; Bhamarapravati N
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):589-99. PubMed ID: 12693596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Derivation and characterization of a dengue type 1 host range-restricted mutant virus that is attenuated and highly immunogenic in monkeys.
    Markoff L; Pang X; Houng Hs HS; Falgout B; Olsen R; Jones E; Polo S
    J Virol; 2002 Apr; 76(7):3318-28. PubMed ID: 11884557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.
    Guirakhoo F; Zhang Z; Myers G; Johnson BW; Pugachev K; Nichols R; Brown N; Levenbook I; Draper K; Cyrek S; Lang J; Fournier C; Barrere B; Delagrave S; Monath TP
    J Virol; 2004 Sep; 78(18):9998-10008. PubMed ID: 15331733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1.
    Blaney JE; Sathe NS; Hanson CT; Firestone CY; Murphy BR; Whitehead SS
    Virol J; 2007 Feb; 4():23. PubMed ID: 17328799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viremia and antibody response in green monkeys (Chlorocebus aethiops sabaeus) infected with dengue virus type 2: a potential model for vaccine testing.
    Martín J; Hermida L; Castro J; Lazo L; Martínez R; Gil L; Romero Y; Puente P; Zaragoza S; Cosme K; Guzmán MG; Cardosa J; Guillén G
    Microbiol Immunol; 2009 Apr; 53(4):216-23. PubMed ID: 19714858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.
    Blaney JE; Matro JM; Murphy BR; Whitehead SS
    J Virol; 2005 May; 79(9):5516-28. PubMed ID: 15827166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.
    Guirakhoo F; Pugachev K; Arroyo J; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Draper K; Monath TP
    Virology; 2002 Jun; 298(1):146-59. PubMed ID: 12093182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the immunization of monkeys against dengue. II. Protection following inoculation of combinations of viruses.
    Halstead SB; Palumbo NE
    Am J Trop Med Hyg; 1973 May; 22(3):375-81. PubMed ID: 4196289
    [No Abstract]   [Full Text] [Related]  

  • 33. Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques.
    Raviprakash K; Porter KR; Kochel TJ; Ewing D; Simmons M; Phillips I; Murphy GS; Weiss WR; Hayes CG
    J Gen Virol; 2000 Jul; 81(Pt 7):1659-67. PubMed ID: 10859370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.
    Guirakhoo F; Arroyo J; Pugachev KV; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Soike K; Ratterree M; Monath TP
    J Virol; 2001 Aug; 75(16):7290-304. PubMed ID: 11462001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biologic properties of dengue viruses following serial passage in primary dog kidney cells: studies at the University of Hawaii.
    Halstead SB; Marchette NJ
    Am J Trop Med Hyg; 2003 Dec; 69(6 Suppl):5-11. PubMed ID: 14740949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Introduction of mutations into the non-structural genes or 3' untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity.
    Hanley KA; Manlucu LR; Manipon GG; Hanson CT; Whitehead SS; Murphy BR; Blaney JE
    Vaccine; 2004 Sep; 22(25-26):3440-8. PubMed ID: 15308370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3' untranslated region is highly attenuated and immunogenic in monkeys.
    Whitehead SS; Falgout B; Hanley KA; Blaney JE; Markoff L; Murphy BR
    J Virol; 2003 Jan; 77(2):1653-7. PubMed ID: 12502885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. II. Attributes of virus cloned at different dog kidney passage levels.
    Halstead SB; Marchette NJ; Diwan AR; Palumbo NE; Putvatana R
    Am J Trop Med Hyg; 1984 Jul; 33(4):666-71. PubMed ID: 6476213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and titration of dengue viruses by the mosquito inoculation technique.
    Choy MM; Gubler DJ
    Methods Mol Biol; 2014; 1138():15-25. PubMed ID: 24696328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetically modified, live attenuated dengue virus type 3 vaccine candidates.
    Blaney JE; Hanson CT; Firestone CY; Hanley KA; Murphy BR; Whitehead SS
    Am J Trop Med Hyg; 2004 Dec; 71(6):811-21. PubMed ID: 15642976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.